These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8447266)

  • 1. Antiarrhythmic and pharmacokinetic evaluation of intravenous recainam in patients with frequent ventricular premature complexes and unsustained ventricular tachycardia.
    Anderson JL; Reddy CP; Myerburg RJ; Waxman HL; de Vane PJ
    Am J Cardiol; 1993 Mar; 71(8):686-94. PubMed ID: 8447266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
    Feld GK; Luceri RM; Greenspon AJ; Singh BN; Horowitz LN; Capuzzi DM; Frame VB; Myerburg RJ
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1129-37. PubMed ID: 1715550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients.
    Hampton EM; Anastasiou-Nana MI; Nanas JN; Nappi JM; Capuzzi DM; Anderson JL
    J Clin Pharmacol; 1987 Dec; 27(12):951-6. PubMed ID: 3437067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recainam, a potent new antiarrhythmic agent: effects on complex ventricular arrhythmias.
    Anastasiou-Nana MI; Anderson JL; Hampton EM; Nanas JN; Heath BM
    J Am Coll Cardiol; 1986 Aug; 8(2):427-35. PubMed ID: 3734265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias.
    Anderson JL; Anastasiou-Nana MI; Heath BM; Menlove RL; Nanas JN; Friedman J
    Am J Cardiol; 1987 Aug; 60(4):281-7. PubMed ID: 2441587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac electrophysiology of the antiarrhythmic agent recainam (Wy-42,362) in anesthetized dogs: relation to plasma and myocardial concentrations.
    Colatsky TJ; Bird LB; Knowles JA
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):308-16. PubMed ID: 2452923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renal function on recainam pharmacokinetics and pharmacodynamics.
    Cheng JW; Charland SL; Goldfarb S; Spinler SA
    Clin Pharmacol Ther; 1995 May; 57(5):492-8. PubMed ID: 7768071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.
    Davies RF; Lineberry MD; Funck-Brentano C; Echt DS; Lee JT; Capuzzi DM; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1989 Sep; 46(3):324-34. PubMed ID: 2673622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes.
    Frame LH; Sheldon JH
    J Am Coll Cardiol; 1988 Sep; 12(3):746-52. PubMed ID: 3403835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT; Campbell RW; McComb JM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):310-5. PubMed ID: 1709237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absolute bioavailability and dose proportionality of intravenous and oral dosage regimens of recainam.
    Troy SM; Cevallos WH; Conrad KA; Chiang ST; Latts JR
    J Clin Pharmacol; 1991 May; 31(5):433-9. PubMed ID: 2050828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the pharmacokinetics of recainam, a new anti-arrhythmic drug.
    Scatina JA; Kimmel HB; Weinstein V; Troy SM; Sisenwine SF; Cayen MN
    Biopharm Drug Dispos; 1990 Jul; 11(5):445-61. PubMed ID: 2207297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
    Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects and efficacy of recainam for sustained ventricular tachycardia.
    de Buitleir M; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am J Cardiol; 1989 Jan; 63(1):116-8. PubMed ID: 2642366
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.
    Bashir Y; Thomsen PE; Kingma JH; Møller M; Wong C; Cobbe SM; Jordaens L; Campbell RW; Rasmussen HS; Camm AJ
    Am J Cardiol; 1995 Nov; 76(14):1040-4. PubMed ID: 7484858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
    Giardina EG; Wechsler ME; Dolgopiatova M; Sciacca R
    J Clin Pharmacol; 1994 Jul; 34(7):725-33. PubMed ID: 7523457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
    Johnson BF; Haffajee CI; Woodman T; Sloan KL
    J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.